Cytokine synergy in antigen-independent activation and priming of naive CD8+ T lymphocytes. 2009

Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
Immunology Division, Department of Pediatrics, Faculty of Medicine and Health Sciences, University of Sherbrooke; Centre de Recherche Clinique Etienne-Le Bel, Centre Hospitalier de I'Universite de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4.

Activation of naive T cells by antigen requires signaling via the T-cell receptor (TCR) and co-stimulatory receptors. However, in response to homeostatic pressure, T lymphocytes undergo cytokine-driven proliferation without overt antigen stimulation. Homeostatic expansion is more pronounced in the CD8+ T-cell compartment, with memory CD8+ T cells showing intense proliferation resulting from increased responsiveness to IL-15. On the other hand, naive CD8+ T cells require IL-7 and MHC-I to undergo homeostatic expansion, implying the requirement for a basal level of TCR signaling. Probably because of this strict requirement for MHC, earlier reports on antigen-independent stimulation of naive human CD8+ T cells by inflammatory cytokines did not receive much attention. Recently, we and others have shown that naive murine CD8+ T cells undergo proliferation following synergistic simulation by inflammatory cytokines. Such cytokine-driven, antigen-independent activation also "sensitizes" or "primes" naive CD8+ T cells, enabling them to respond robustly to limiting concentrations of cognate antigens, produce effector cytokines abundantly, and display potent cytolytic activity. We propose that cytokine synergy, which induces antigen-independent activation and priming of naive CD8+ T cells, may significantly contribute to the transition from innate to adaptive immune response and to inadvertent activation of autoreactive CD8+ T cells.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities

Related Publications

Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
April 2014, Nature protocols,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
September 1994, The Journal of experimental medicine,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
February 2000, The Journal of experimental medicine,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
April 2018, Immunology,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
August 2001, Journal of immunology (Baltimore, Md. : 1950),
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
December 2021, eLife,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
October 2003, Blood,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
January 1998, European journal of immunology,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
June 1987, European journal of immunology,
Sheela Ramanathan, and Julien Gagnon, and Stephanie Dubois, and Melissa Forand-Boulerice, and Martin V Richter, and Subburaj Ilangumaran
June 1991, Immunology today,
Copied contents to your clipboard!